| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9eb55107a8f305b75506e5eae7bcf902 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M11-002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M11-042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M11-041
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M11-047 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M11-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M11-04 |
| filingDate |
2003-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0886f9ec30cdc7afc15679699de4d4ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_730e8ccd7636972c38e5da0203041bf3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66a9402cd6faa76a8daf9fb51a04dbb8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8dba471c8c2528f6cca135bef445f353
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_066fd502cbb9329d371ae04b0b15963b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0431886411dd42d73d74a912a1922f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_471fbf69f6e2adfe2356d1b3b7047a3a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_032a10e91f73155cf07b025bf01ac82e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39722a65e3334469f5659aaea21e9a94 |
| publicationDate |
2004-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2004050139-A2 |
| titleOfInvention |
Inhalation device for producing a drug aerosol |
| abstract |
A device for delivering a drug by inhalation is disclosed. The device includes a body defining an interior flow-through chamber having upstream and downstream chamber openings, and a drug supply unit contained within the chamber for producing, upon actuation, a heated drug vapor in a condensation region of the chamber. Gas drawn through the chamber region at a selected gas-flow rate is effective to form drug condensation particles from the drug vapor having a selected MMAD between 0.02 and 0.1 MMAD or between 1 and 3.5 gm. A gas-flow control valve disposed upstream of the unit functions to limit gas-flow rate through the condensation region to the selected gas-flow rate. An actuation switch in the device activates the drug-supply unit, such that the drug-supply unit can be controlled to produce vapor when the gas-flow rate through the chamber is at the selected flow rate. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004104490-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3794971-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016040575-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008509907-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8899230-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3191162-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11089660-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10194693-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009102976-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10034988-B2 |
| priorityDate |
2002-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |